Actavis Aquisition of Allergan Set to Proceed Early
Thursday, January 15 2015 | 00 h 00 min | Acquisitions
The U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for Actavis’ pending acquisition of Allergan. The close of business record date has been set for January 22, 2015 for shareholder meetings.
The two companies combined will create one of the top 10 global growth pharmaceuticals with expected revenue of $23 billion in 2015.
Read the full press release here: http://agn.client.shareholder.com/releaseDetail.cfm?ReleaseID=890722
